Esco Ventures announces our participation in NanoView Diagnostics, Inc. Series A Financing.

May 4, 20171 min read

Based in Boston, NanoView Diagnostics, Inc. is striving to becoming the leader in exosomes analysis for the basic-research, therapeutic development, and medical diagnostics, by enabling high-throughput detection of nanoparticles from complex samples such as whole blood, serum, and plasma.

Recent Posts

See All

Congratulations to the Inaugural PLATINUM Grant Awardees

Congratulations to Dr Torsten Wuestefeld, Dr Sherry Aw, and Dr Dave Wee for being awarded the inaugural PLATINUM Grant!

Esco Ventures Announces the Launch of Carmine Therapeutics

30 August 2019 – Esco Ventures is pleased to announce the launch of Carmine Therapeutics and Carmine Therapeutics plans to establish a...

Graduation of Inaugural Batch of Morphosis Fellows

Esco Ventures is proud to announce that our first batch of fellows have officially graduated and we're now embarking on Morphosis II....

Esco Ventures announces our participation in NanoView Diagnostics, Inc. Series A Financing.

Recent Posts

Comments